These medications mimic the action of the hormone GLP-1 (glucagon-like peptide-1), which helps manage blood sugar levels by stimulating insulin release, reducing glucagon secretion, and slowing gastric emptying
That approach can fail when hunger hormones, cravings, stress, sleep disruption, insulin resistance, or metabolic adaptation push the body back toward weight regain
The introduction of this product into humans or animals is strictly prohibited and may violate applicable laws and regulations
GLP-1 patches are skin-based treatments that promise the same results as injectable GLP-1s without needles and at a lower price
The key is being patient with the process and working closely with your healthcare team
Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial [Press release]